These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38753870)

  • 1. Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions.
    Hou Y; Chu X; Park JH; Zhu Q; Hussain M; Li Z; Madsen HB; Yang B; Wei Y; Wang Y; Fang EF; Croteau DL; Bohr VA
    Alzheimers Dement; 2024 Jun; 20(6):4212-4233. PubMed ID: 38753870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice.
    Gong Z; Huang J; Xu B; Ou Z; Zhang L; Lin X; Ye X; Kong X; Long D; Sun X; He X; Xu L; Li Q; Xuan A
    J Neuroinflammation; 2019 Mar; 16(1):62. PubMed ID: 30871577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer's Disease.
    Jayatunga DPW; Hone E; Khaira H; Lunelli T; Singh H; Guillemin GJ; Fernando B; Garg ML; Verdile G; Martins RN
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urolithin A reduces amyloid-beta load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer's disease.
    Ballesteros-Álvarez J; Nguyen W; Sivapatham R; Rane A; Andersen JK
    Geroscience; 2023 Apr; 45(2):1095-1113. PubMed ID: 36576642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson's disease model.
    Qiu J; Chen Y; Zhuo J; Zhang L; Liu J; Wang B; Sun D; Yu S; Lou H
    Neuropharmacology; 2022 Apr; 207():108963. PubMed ID: 35065082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urolithin A promotes p62-dependent lysophagy to prevent acute retinal neurodegeneration.
    Jiménez-Loygorri JI; Viedma-Poyatos Á; Gómez-Sintes R; Boya P
    Mol Neurodegener; 2024 Jun; 19(1):49. PubMed ID: 38890703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric Acid Mitigates Cognitive Deficits via TFEB-Mediated Microglial Autophagy in Mice Models of Alzheimer's Disease.
    Xiao Q; Wang J; Tian Q; Tian N; Tian Q; He X; Wang Y; Dong Z
    Mol Neurobiol; 2024 Jun; 61(6):3678-3696. PubMed ID: 38008888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Urolithin A on Mitochondrial Parameters in a Cellular Model of Early Alzheimer Disease.
    Esselun C; Theyssen E; Eckert GP
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer's disease.
    Roca-Agujetas V; Barbero-Camps E; de Dios C; Podlesniy P; Abadin X; Morales A; Marí M; Trullàs R; Colell A
    Mol Neurodegener; 2021 Mar; 16(1):15. PubMed ID: 33685483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urolithin A exhibits a neuroprotective effect against Alzheimer's disease by inhibiting DYRK1A activity.
    Tu HJ; Su CJ; Peng CS; Lin TE; HuangFu WC; Hsu KC; Hwang TL; Pan SL
    J Food Drug Anal; 2023 Jun; 31(2):358-370. PubMed ID: 37335158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease.
    Fang EF; Hou Y; Palikaras K; Adriaanse BA; Kerr JS; Yang B; Lautrup S; Hasan-Olive MM; Caponio D; Dan X; Rocktäschel P; Croteau DL; Akbari M; Greig NH; Fladby T; Nilsen H; Cader MZ; Mattson MP; Tavernarakis N; Bohr VA
    Nat Neurosci; 2019 Mar; 22(3):401-412. PubMed ID: 30742114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer's Disease.
    Kshirsagar S; Alvir RV; Pradeepkiran JA; Hindle A; Vijayan M; Ramasubramaniam B; Kumar S; Reddy AP; Reddy PH
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of cytosolic cathepsin D in Alzheimer's disease pathology: Protective cellular effects of PLGA nanoparticles against β-amyloid-toxicity.
    Wang Y; Wu Q; Anand BG; Karthivashan G; Phukan G; Yang J; Thinakaran G; Westaway D; Kar S
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):686-706. PubMed ID: 32716575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term running exercise alleviates cognitive dysfunction in APP/PSEN1 transgenic mice via enhancing brain lysosomal function.
    Wang X; Zhu YT; Zhu Y; Sun YL; Huang J; Li Z; Wang Y; Wu JC; Qin ZH; Lin F
    Acta Pharmacol Sin; 2022 Apr; 43(4):850-861. PubMed ID: 34272505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are mitophagy enhancers therapeutic targets for Alzheimer's disease?
    Pradeepkiran JA; Hindle A; Kshirsagar S; Reddy PH
    Biomed Pharmacother; 2022 May; 149():112918. PubMed ID: 35585708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Asarone improves learning and memory in Aβ
    Han Y; Wang N; Kang J; Fang Y
    Metab Brain Dis; 2020 Oct; 35(7):1109-1117. PubMed ID: 32556928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models.
    Butler D; Hwang J; Estick C; Nishiyama A; Kumar SS; Baveghems C; Young-Oxendine HB; Wisniewski ML; Charalambides A; Bahr BA
    PLoS One; 2011; 6(6):e20501. PubMed ID: 21695208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease.
    Kshirsagar S; Sawant N; Morton H; Reddy AP; Reddy PH
    Pharmacol Res; 2021 Dec; 174():105973. PubMed ID: 34763094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.
    Yang DS; Stavrides P; Mohan PS; Kaushik S; Kumar A; Ohno M; Schmidt SD; Wesson D; Bandyopadhyay U; Jiang Y; Pawlik M; Peterhoff CM; Yang AJ; Wilson DA; St George-Hyslop P; Westaway D; Mathews PM; Levy E; Cuervo AM; Nixon RA
    Brain; 2011 Jan; 134(Pt 1):258-77. PubMed ID: 21186265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer's Disease and Parkinson's Disease and Models of Mild Cognitive Impairment.
    Hwang J; Estick CM; Ikonne US; Butler D; Pait MC; Elliott LH; Ruiz S; Smith K; Rentschler KM; Mundell C; Almeida MF; Stumbling Bear N; Locklear JP; Abumohsen Y; Ivey CM; Farizatto KLG; Bahr BA
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.